pharmacology aspirin heparin coumarin thrombolytic agents Implications therapeutic use cardiopulmonary disease modern treatment cardiopulmonary disease goal clot vascular patency possible rethrombosis availability thrombolytic agents therapeutic approach possible adjunctive use heparin coumarin aspirin efficacy lytic drugs administration medications inherent risks understanding coagulation appreciation pathophysiologic processes thrombotic events cardiopulmonary disease states critical formulation innovative therapeutic regimens efficacy safety Furthermore knowledge comparative pharmacology various thrombolytic agents useful benefits complications clinical trials 